Viscosupplementation Market, Global Forecast Report by by Product (Single Injection Viscosupplementation, Three Injections Viscosupplementation and Five Injections Viscosupplementation), By Application (Knee, Hip, Hand/Wrist, Ankle/Foot, and Others), by End User (Hospitals, Orthopedic Clinics/Ambulatory Surgical Centres), Regions and Company Analysis 2024-2030
Buy NowViscosupplementation Market Outlook
Global Viscosupplementation market size is projected to reach US$ 7.81 Billion by 2030, as per Renub Research. Hyaluronic acid (HA) injections are typically used for treating localized osteoarthritis (OA) due to their easy application and tolerability. Many HA derivatives are available, with various properties and ranges of proof. Viscosupplementation is moderately but appreciably effective in reducing pain and improving feature in comparison to a placebo. It has a high rate of positive responses while used to treat knee osteoarthritis. It can help lessen the need for opioid analgesics and NSAIDs, ensuing in an improved risk/gain ratio, and might additionally put off the need for joint replacement.
The prevalence of age-related illnesses is increasing with the arena's growing older populace, with osteoarthritis being the maximum commonplace joint disorder. Osteoarthritis is related to excessive scientific and social changes. Viscosupplementation, which involves injecting hyaluronic acid derivatives into the joint, is becoming a more famous remedy method. The materials applied in this procedure are high molecular-weight polysaccharides. These distribute weight, lubricate the joint and exhibit anti-inflammatoryproperties. Additionally, those drugs exert physical-chemical outcomes on various joint characteristics. The importance of those results is contingent upon the molecular weight and attention of the drug, alongside the presence of any cross-links within the drug.
Viscosupplementation Market is expected to grow at a compound annual growth rate (CAGR) of 8.97% from 2024 to 2030
Viscosupplementation, an outpatient procedure, effectively alleviates pain and enhances joint function in osteoarthritis patients. It contributes to the augmentation of joint cartilage in terms of quality and quantity. With a commendable safety record and cost-effectiveness, this procedure is often recommended post-arthroscopy. Knee and hip osteoarthritis prevalence is rising among older people due to age-related factors impacting cartilage strength and flexibility. The aging population, expected to double to 1.5 billion by 2050, is a global trend reported by the United Nations. By 2043, seniors constituted about 25% of Canada's total population, as per government statistics.
The viscosupplementation market is expanding, propelled by the widespread adoption of key strategies like collaboration, acquisition, agreements, and company partnerships. A primary growth driver is the increasing prevalence of osteoporosis and osteoarthritis (OA). This has led to heightened adoption of viscosupplementation in the healthcare sector for managing joint pain—an appealing, minimally invasive alternative to corticosteroids. The market benefits significantly from this shift. Moreover, consumer awareness of the advantages of non-surgical treatments, including cost-effectiveness, absence of hospitalization, minimal complications, and improved clinical outcomes, amplifies this trend, further fueling the market's growth.
Favorable government policies and substantial investments by pharmaceutical companies in novel drugs and alternative administration routes propel growth in the healthcare industry. This expansion is bolstered by the emergence of ambulatory surgical centers (ACS), addressing surgical and non-surgical issues in joints, ligaments, muscles, spine, and nerves. The market receives an additional boost from introducing open-label single-injections with hyaluronic acid, actively driving industry growth.
The viscosupplementation market is experiencing positive impacts from factors like favorable health insurance reimbursement policies, a growing population with chronic disabilities, and an increasing geriatric demographic susceptible to chronic ailments. Collaborations, partnerships, and continuous research and development (R&D) activities in the medical sciences further contribute to this growth. In 2023, the viscosupplementation market reached a valuation of US$ 4.28 Billion.
Segment of single-injection viscosupplementation is anticipated to experience growth in the future
The Viscosupplementation market is segmented by Product into Single Injection, Three Injection, and Five Injection. The single-injection viscosupplementation segment is poised for substantial growth in the coming years. This anticipated expansion is attributed to several factors:
- The single-injection approach provides enhanced convenience for both physicians and patients.
- There is a rising demand for outpatient surgeries, particularly those emphasizing same-day surgical care, encompassing preventive and diagnostic procedures.
- Companies are intensifying their efforts to develop single-injection treatments for osteoarthritis, resulting in increased product launches.
The growing focus on offering efficient solutions for osteoarthritis patients aligns with the overall strategy of developing single-injection products, contributing to the anticipated growth of the viscosupplementation market throughout the forecast period.
Knee osteoarthritis emerged as the dominant force in the viscosupplementation market
By application, the Viscosupplementation market is divided into Knee, Hip, Hand/Wrist, Ankle/Foot, and Others. The knee osteoarthritis segment has asserted its dominance in the viscosupplementation market, primarily fueled by the escalating prevalence of knee osteoarthritis and the increasing geriatric population, which is more prone to this condition. The aging demographic is particularly susceptible to knee osteoarthritis due to the aging process, leading to a reduction in the water content of cartilage. This diminishes its capacity to absorb shock and provide cushioning, making older people more susceptible to knee-related ailments. The significant prevalence of knee osteoarthritis and its correlation with age underscore the prominence of this segment within the viscosupplementation market.
Orthopedic clinics/Ambulatory Surgical Centers market is rising year on year
By End User, the Viscosupplementation market is classified into Hospitals and orthopedic clinics/Ambulatory Surgical Centers. The orthopedic clinics and ambulatory surgical centers market is witnessing consistent annual growth. This trend indicates the increasing demand for specialized orthopedic services and the adoption of outpatient surgical procedures. Patients increasingly prefer these facilities for convenience, efficient services, and reduced hospitalization time. Additionally, advancements in medical technology and the emphasis on providing comprehensive orthopedic care contribute to the sustained expansion of this market. As healthcare continues to evolve towards more patient-centric models, the growth of orthopedic clinics and ambulatory surgical centers reflects the changing landscape of orthopedic healthcare services.
China will be the second-largest contributor to the market
By Countries, Viscosupplementation market is split into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), South America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, UAE). The expansion of the viscosupplementation market in China is influenced by diverse factors such as population demographics, disease incidence, prevalence, macroeconomic conditions, and geopolitical considerations. Market fluctuations may arise from unexpected shifts in these elements and alterations in clinical practices that result in modifications to patient diagnosis or treatment approaches, reflecting a broader effort to enhance overall medical practices.
The U.S. viscosupplementation market is growing due to a rising osteoarthritis population seeking non-surgical solutions. As per the CDC, about 34.5 million Americans contend with osteoarthritis annually, marked by reduced hyaluronic acid leading to pain and stiffness. Increased interest in non-surgical options, driven by concerns over surgery and treatment costs, contributes to market growth. Ongoing advancements in hyaluronic acid therapies, tailored by key players for swift knee pain relief, further propel the market. Researchers are also exploring diverse strategies to impede the progression of knee pain disorders amidst this growth trend.
Key Player
Anika Therapeutics Inc., Zimmer Biomet, Smith & Nephew PLC, F.Hoffmann-La Roche Ltd, Sanofi, Chugai Pharmaceutical Co., Lifecore Biomedical, and LG Life Sciences Ltd are the leading companies in the Viscosupplementation market.
Renub Research latest report “Global Viscosupplementation Market Forecast by Product (Single Injection Viscosupplementation, Three Injections Viscosupplementation and Five Injections Viscosupplementation), By Application (Knee, Hip, Hand/Wrist, Ankle/Foot, and Others), by End User (Hospitals, Orthopedic Clinics/Ambulatory Surgical Centres), By Region (North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, New Zealand), South America (Brazil, Mexico, Argentina), Middle East & Africa (South Africa, Saudi Arabia, UAE)), Key Players Analysis (Anika Therapeutics Inc, Zimmer Biomet, Smith & Nephew PLC, F.Hoffmann-La Roche Ltd, Sanofi, Chugai Pharmaceutical Co, Lifecore Biomedical and LG Life Sciences Ltd)” provides a detailed analysis of Global Viscosupplementation Industry.
Product – Market have been covered from 3 viewpoints
1. Single Injection Viscosupplementation
2. Three Injections Viscosupplementation
3. Five Injections Viscosupplementation
Application – Market have been covered from 5 viewpoints
1. Knee
2. Hip
3. Hand/Wrist
4. Ankle/Foot
5. Others
End User – Market have been covered from 2 viewpoints
1. Hospitals
2. Orthopedic clinics/Ambulatory Surgical Centers
Region – Market have been covered from 25 Countries viewpoints
1. North America
1.1 United States
1.2 Canada
2. Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherlands
2.8 Turkey
3. Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
4. Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
5. Middle East & Africa
5.1 Saudi Arabia
5.2 United Arab Emirates
5.3 South Africa
Company Analysis
• Overview
• Recent Development
• Revenue
Companies Covered
1. Anika Therapeutics Inc
2. Zimmer Biomet
3. Smith & Nephew PLC
4. F.Hoffmann-La Roche Ltd
5. Sanofi
6. Chugai Pharmaceutical Co
7. Lifecore Biomedical
8. LG Life Sciences Ltd
Report Details:
| Report Features | Details |
| Base Year | 2023 |
| Historical Period | 2018 - 2023 |
| Forecast Period | 2024 - 2030 |
| Market | US$ Billion |
| Segment Covered | Product, Application, End User, and Countries |
| Countries Covered | United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, and South Africa |
| Companies Covered | Anika Therapeutics Inc, Zimmer Biomet, Smith & Nephew PLC, F.Hoffmann-La Roche Ltd, Sanofi, Chugai Pharmaceutical Co, Lifecore Biomedical and LG Life Sciences Ltd |
| Customization Scope | 20% Free Customization |
| Post-Sale Analyst Support | 1 Year (52 Weeks) |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Viscosupplementation Market
6. Market Share – Global Viscosupplementation Market
6.1 By Product
6.2 By Application
6.3 By End User
6.4 By Countries
7. Product – Global Viscosupplementation Market
7.1 Single Injection
7.2 Three Injection
7.3 Five Injection
8. Application – Global Viscosupplementation Market
8.1 Knee Osteoarthritis
8.2 Hip Osteoarthritis
8.3 Hand/Wrist Osteoarthritis
8.4 Ankle/Foot Osteoarthritis
8.5 Others
9. End User – Global Viscosupplementation Market
9.1 Hospitals
9.2 Orthopedic clinics/Ambulatory Surgical Centers
10. Countries – Global Viscosupplementation Market
10.1 North America
10.1.1 United States
10.1.2 Canada
10.2 Europe
10.2.1 France
10.2.2 Germany
10.2.3 Italy
10.2.4 Spain
10.2.5 United Kingdom
10.2.6 Belgium
10.2.7 Netherlands
10.2.8 Turkey
10.3 Asia Pacific
10.3.1 China
10.3.2 Japan
10.3.3 India
10.3.4 South Korea
10.3.5 Thailand
10.3.6 Malaysia
10.3.7 Indonesia
10.3.8 Australia
10.3.9 New Zealand
10.4 Latin America
10.4.1 Brazil
10.4.2 Mexico
10.4.3 Argentina
10.5 Middle East & Africa
10.5.1 Saudi Arabia
10.5.2 United Arab Emirates
10.5.3 South Africa
11. Porter’s Five Forces – Global Viscosupplementation Market
11.1 Bargaining Power of Buyer
11.2 Bargaining Power of Supplier
11.3 Threat of New Entrants
11.4 Rivalry among Existing Competitors
11.5 Threat of Substitute Products
12. SWOT Analysis – Global Viscosupplementation Market
12.1 Strengths
12.2 Weaknesses
12.3 Opportunities
12.4 Threats
13. Key Players Analysis
13.1 Anika Therapeutics, Inc.
13.1.1 Company overview
13.1.2 Recent Development
13.1.3 Sales Analysis
13.2 Zimmer Biomet
13.2.1 Company overview
13.2.2 Recent Development
13.2.3 Sales Analysis
13.3 Smith & Nephew PLC
13.3.1 Company overview
13.3.2 Recent Development
13.3.3 Sales Analysis
13.4 F.Hoffmann-La Roche Ltd.
13.4.1 Company overview
13.4.2 Recent Development
13.4.3 Sales Analysis
13.5 Sanofi
13.5.1 Company overview
13.5.2 Recent Development
13.5.3 Sales Analysis
13.6 Chugai Pharmaceutical Co.
13.6.1 Company overview
13.6.2 Recent Development
13.6.3 Sales Analysis
13.7 Lifecore Biomedical
13.7.1 Company overview
13.7.2 Recent Development
13.7.3 Sales Analysis
13.8 LG Life Sciences Ltd.
13.8.1 Company overview
13.8.2 Recent Development
13.8.3 Sales Analysis
List of Figures:
Figure-01: Global – Viscosupplementation Market (Billion US$), 2018 – 2023
Figure-02: Global – Forecast for Viscosupplementation Market (Billion US$), 2024 – 2030
Figure-03: Product – Single Injection Market (Million US$), 2018 – 2023
Figure-04: Product – Forecast for Single Injection Market (Million US$), 2024 – 2030
Figure-05: Product – Three Injection Market (Million US$), 2018 – 2023
Figure-06: Product – Forecast for Three Injection Market (Million US$), 2024 – 2030
Figure-07: Product – Five Injection Market (Million US$), 2018 – 2023
Figure-08: Product – Forecast for Five Injection Market (Million US$), 2024 – 2030
Figure-09: Application – Knee Osteoarthritis Market (Million US$), 2018 – 2023
Figure-10: Application – Forecast for Knee Osteoarthritis Market (Million US$), 2024 – 2030
Figure-11: Application – Hip Osteoarthritis Market (Million US$), 2018 – 2023
Figure-12: Application – Forecast for Hip Osteoarthritis Market (Million US$), 2024 – 2030
Figure-13: Application – Hand/Wrist Osteoarthritis Market (Million US$), 2018 – 2023
Figure-14: Application – Forecast for Hand/Wrist Osteoarthritis Market (Million US$), 2024 – 2030
Figure-15: Application – Ankle/Foot Osteoarthritis Market (Million US$), 2018 – 2023
Figure-16: Application – Forecast for Ankle/Foot Osteoarthritis Market (Million US$), 2024 – 2030
Figure-17: Application – Others Market (Million US$), 2018 – 2023
Figure-18: Application – Forecast for Others Market (Million US$), 2024 – 2030
Figure-19: End User – Hospitals Market (Million US$), 2018 – 2023
Figure-20: End User – Forecast for Hospitals Market (Million US$), 2024 – 2030
Figure-21: End User – Orthopedic clinics/Ambulatory Surgical Centers Market (Million US$), 2018 – 2023
Figure-22: End User – Forecast for Orthopedic clinics/Ambulatory Surgical Centers Market (Million US$), 2024 – 2030
Figure-23: United States – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-24: United States – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-25: Canada – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-26: Canada – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-27: France – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-28: France – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-29: Germany – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-30: Germany – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-31: Italy – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-32: Italy – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-33: Spain – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-34: Spain – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-35: United Kingdom – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-36: United Kingdom – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-37: Belgium – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-38: Belgium – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-39: Netherlands – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-40: Netherlands – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-41: Turkey – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-42: Turkey – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-43: China – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-44: China – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-45: Japan – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-46: Japan – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-47: India – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-48: India – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-49: South Korea – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-50: South Korea – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-51: Thailand – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-52: Thailand – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-53: Malaysia – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-54: Malaysia – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-55: Indonesia – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-56: Indonesia – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-57: Australia – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-58: Australia – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-59: New Zealand – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-60: New Zealand – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-61: Brazil – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-62: Brazil – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-63: Mexico – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-64: Mexico – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-65: Argentina – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-66: Argentina – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-67: Saudi Arabia – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-68: Saudi Arabia – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-69: United Arab Emirates – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-70: United Arab Emirates – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-71: South Africa – Viscosupplementation Market (Million US$), 2018 – 2023
Figure-72: South Africa – Forecast for Viscosupplementation Market (Million US$), 2024 – 2030
Figure-73: Anika Therapeutics, Inc. – Global Revenue (Million US$), 2018 – 2023
Figure-74: Anika Therapeutics, Inc. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-75: Zimmer Biomet – Global Revenue (Million US$), 2018 – 2023
Figure-76: Zimmer Biomet – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-77: Smith & Nephew PLC – Global Revenue (Million US$), 2018 – 2023
Figure-78: Smith & Nephew PLC – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-79: F.Hoffmann-La Roche Ltd. – Global Revenue (Million US$), 2018 – 2023
Figure-80: F.Hoffmann-La Roche Ltd. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-81: Sanofi – Global Revenue (Million US$), 2018 – 2023
Figure-82: Sanofi – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-83: Chugai Pharmaceutical Co. – Global Revenue (Million US$), 2018 – 2023
Figure-84: Chugai Pharmaceutical Co. – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-85: Lifecore Biomedical – Global Revenue (Million US$), 2018 – 2023
Figure-86: Lifecore Biomedical – Forecast for Global Revenue (Million US$), 2024 – 2030
Figure-87: LG Life Sciences Ltd. – Global Revenue (Million US$), 2018 – 2023
Figure-88: LG Life Sciences Ltd. – Forecast for Global Revenue (Million US$), 2024 – 2030
List of Tables:
Table-01: Global – Viscosupplementation Market Share by Product (Percent), 2018 – 2023
Table-02: Global – Forecast for Global Viscosupplementation Market Share by Product (Percent), 2024 – 2030
Table-03: Global – Viscosupplementation Market Share by Category (Percent), 2018 – 2023
Table-04: Global – Forecast for Global Viscosupplementation Market Share by Category (Percent), 2024 – 2030
Table-05: Global – Viscosupplementation Market Share by Type (Percent), 2018 – 2023
Table-06: Global – Forecast for Global Viscosupplementation Market Share by Type (Percent), 2024 – 2030
Table-07: Global – Viscosupplementation Market Share by Countries (Percent), 2018 – 2023
Table-08: Global – Forecast for Global Viscosupplementation Market Share by Countries (Percent), 2024 – 2030
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com